Blockbuster GLP-1 medications like Ozempic and Mounjaro might sharpen your figure, but they could also cloud your vision in ...

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

A teenage girl presented to the hospital emergency department with a three-week history of intermittent frontal headache, which was worse in the morning and associated with nausea, vomiting, lethargy, ...

In this Healio Video Perspective from Hawaiian Eye 2025, Riad Sherif, MD, CEO of Oculis, discusses data on OCS-05 for the ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

Compr Ophthalmol Update. 2005;6(1):11-21. As can be seen in Table 2, untreated cases of TON improve even when the initial vision is no light perception. This rate of spontaneous visual improvement ...

Demyelinating lesions can affect different ... Other eye conditions, such as optic neuritis and diplopia, are also known to affect many people with MS. Optic neuritis is a common vision problem ...

Polyneuropathy is also known as peripheral neuropathy. Peripheral nerves are nerves located outside the brain and spinal cord. They relay information between the central nervous system (CNS ...

An ophthalmologist examined all lupus patients and visual evoked potential (VEP) was performed to help evaluate the rule of NMUS in lupus-induced optic neuropathy. Results In this study, we include ...

Riliprubart is under clinical development by Sanofi and currently in Phase III for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). According to GlobalData, Phase III drugs for Chronic ...